Covered recipient · General Payments record
ANITA TIPIRNENI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2024
$5,269.71
- Reported across 246 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $456.65 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $165.24 | 6 |
| PFIZER INC. | $122.75 | 5 |
| UCB, Inc. | $72.27 | 3 |
| Neurocrine BioSciences, Inc. | $60.21 | 3 |
| Amneal Pharmaceuticals LLC | $18.38 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.28 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106227717 | CMS |
| ABBVIE INC. | $34.92 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106227719 | CMS |
| ABBVIE INC. | $28.43 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106227721 | CMS |
| ABBVIE INC. | $33.65 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106227723 | CMS |
| ABBVIE INC. | $14.29 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106227725 | CMS |
| ABBVIE INC. | $29.67 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106227727 | CMS |
| Amneal Pharmaceuticals LLC | $18.38 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139203850 | CMS |
| Neurocrine Biosciences, Inc. | $29.49 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150826922 | CMS |
| Neurocrine Biosciences, Inc. | $17.25 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150868106 | CMS |
| Neurocrine Biosciences, Inc. | $13.47 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150878675 | CMS |
| Novartis Pharmaceuticals Corporation | $17.80 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087439546 | CMS |
| PFIZER INC. | $27.63 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131525456 | CMS |
| PFIZER INC. | $23.62 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131758400 | CMS |
| PFIZER INC. | $21.35 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132086234 | CMS |
| PFIZER INC. | $28.77 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130879908 | CMS |
| PFIZER INC. | $21.38 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131001417 | CMS |
| UCB, Inc. | $26.11 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143162198 | CMS |
| UCB, Inc. | $25.54 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143162200 | CMS |
| UCB, Inc. | $20.62 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143162202 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.